kainos loboratories,inc
4556 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 文京区本郷二丁目３８番１８号
- Website:
- https://www.kainos.co.jp/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Kainos Laboratories, Inc. is a pioneering Japanese company specializing in the development and production of innovative clinical testing reagents. With a commitment to enhancing healthcare through scientific advancement, Kainos integrates creative power and innovation to deliver high-quality solutions that encourage joy, respect, and fun in the medical field. The company is dedicated to supporting a more sustainable society by providing cutting-edge reagents that facilitate accurate and efficient clinical testing. Kainos Laboratories stands at the forefront of the industry, striving to improve health outcomes globally while fostering a culture of creativity and progress.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-20 03:02 |
Internal Control over Financial Reporting
内部統制報告書－第50期(2024/04/01－2025/03/31)
|
Japanese | 21.9 KB | |
| 2025-06-20 03:00 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-06-20 02:59 |
Annual Report
有価証券報告書－第50期(2024/04/01－2025/03/31)
|
Japanese | 710.6 KB | |
| 2025-06-20 02:56 |
Inside Information Statement
臨時報告書
|
Japanese | 23.6 KB | |
| 2024-11-06 01:39 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-11-06 01:38 |
Interim Report
半期報告書－第50期(2024/04/01－2025/03/31)
|
Japanese | 160.1 KB | |
| 2024-06-21 03:08 |
Inside Information Statement
臨時報告書
|
Japanese | 22.5 KB | |
| 2024-06-21 03:06 |
Internal Control over Financial Reporting
内部統制報告書－第49期(2023/04/01－2024/03/31)
|
Japanese | 21.1 KB | |
| 2024-06-21 03:04 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-06-21 03:02 |
Annual Report
有価証券報告書－第49期(2023/04/01－2024/03/31)
|
Japanese | 704.8 KB | |
| 2024-02-02 01:39 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-02-02 01:38 |
Quarterly Report
四半期報告書－第49期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 135.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
GNI Group Ltd. | Japan | 2160 | |
|
Gour Medical | France | MLGML | |
|
Grifols S.A. | Spain | GRF | |
|
Grindeks | Latvia | GRD1R | |
|
Guerbet | France | GBT | |
|
Haemato AG | Germany | HAEK | |
|
Halychpharm | Ukraine | GFARM | |
|
Hamlet BioPharma AB | Sweden | HAMLET | |
|
Harm Reduction Group AB | Sweden | NOHARM | |
|
HEALIOS K.K. | Japan | 4593 |